TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biogen Norway AS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
250,658
|
300,646
|
395,222 |
Financial expenses |
15
|
245
|
400 |
Earnings before taxes |
12,035
|
10,111
|
18,030 |
Total assets |
208,037
|
209,747
|
222,062 |
Current assets |
207,858
|
209,472
|
221,714 |
Current liabilities |
37,109
|
36,726
|
61,881 |
Equity capital |
170,928
|
173,020
|
160,181 |
- share capital |
99
|
106
|
103 |
Employees (average) |
26
|
19 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
82.2%
|
82.5%
|
72.1% |
Turnover per employee |
11,563
|
20,801 | |
Profit as a percentage of turnover |
4.8%
|
3.4%
|
4.6% |
Return on assets (ROA) |
5.8%
|
4.9%
|
8.3% |
Current ratio |
560.1%
|
570.4%
|
358.3% |
Return on equity (ROE) |
7.0%
|
5.8%
|
11.3% |
Change turnover |
-30,068
|
-106,822
|
-90,247 |
Change turnover % |
-11%
|
-26%
|
-19% |
Chg. No. of employees |
7
|
2 | |
Chg. No. of employees % |
37%
|
12% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.